MONMOUTH JUNCTION, N.J., May 1, 2019 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report...
from PR Newswire: https://prn.to/2IUOd55
No comments:
Post a Comment